ABUS for Early-stage Breast Cancer

Status Recruiting

Clinical Trial Summary

While the role of automated breast ultrasound (ABUS) as an alternative to hand-held ultrasound (HHUS) in breast cancer screening has been established, the use of ABUS in preoperative evaluation of newly diagnosed breast cancer patients is still limited. This may be because axillary areas are not included in the scanning area of ABUS. Newly diagnosed breast cancer patients have undergone axillary US to predict axillary lymph node metastasis before surgery, in combination with preoperative breast US, in many institutions. However, recent studies have reported that sentinel lymph node biopsy alone is sufficient for diagnosis and treatment of axillae of patients with early-stage breast cancer, because the incidence of axillary lymph node metastasis is very low. Therefore, the clinical significance of preoperative axillary US is being lowered in patients with early-stage breast cancers. Thus, considering that coronal images provided by ABUS may be more advantageous for detection of multifocal or multicentric cancer, we hypothesized that ABUS could replace HHUS in preoperative staging of patients with early-stage breast cancers (clinical Tis, T1-2/N0 cancers) for whom preoperative axillary US is not necessary. The purpose of this study was to prospectively compare the diagnostic performances of ABUS and HHUS in preoperative evaluation of patients with early-stage breast cancers. This study will be conducted with institutional review board approval, and written informed consent will be obtained. From the Jan 2019 to Dec 2021, 675 patients diagnosed with early-stage breast cancer will be enrolled from the three institutions. Both ABUS and HHUS will be performed on each patient before surgery. Breast radiologists independently review ABUS and HHUS images. They detect all visible lesions and record the location and size of them. They characterize all detected lesions by using BI-RADS category. The primary object is to compare the diagnostic performance of ABUS and HHUS as preoperative staging tool in women with known breast cancers. The sensitivities and specificity of each US mode for the detection of breast cancers are calculated on a per-lesion basis. McNemar's test and Fisher's exact test are used to compare the sensitivities and PPVs for ABUS and HHUS. Significance testing on the lesion level and patient level is conducted using generalized estimating equations (GEEs) with a logit link and an independent working correlation structure to adjust the effect of clustering on radiologists and patients. GEEs are utilized to compare the sensitivities and PPVs for ABUS and HHUS. Diagnostic performance are assessed with receiver operating characteristics curve analysis. Area under the curves are calculated from both parametric and trapezoidal curve fitting. Agreements between tumor size measured by each US mode and pathologic the tumor size are analyzed with the intraclass correlation coefficient (ICC) and 95% Bland-Altman limits of agreement.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04607473
Study type	Interventional
Source	Samsung Medical Center
Contact	Ji Soo Choi, MD,PhD
Phone	82-2-3410-3902
Email	jisoo.choi@samsung.com
Status	Recruiting
Phase	N/A
Start date	August 15, 2019
Completion date	August 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02816112` - Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia	Phase 4
Completed	`NCT02816164` - A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia	Phase 4
Completed	`NCT03946683` - Cyberknife for Early Stage Breast Cancer	N/A
Recruiting	`NCT04458532` - Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer	N/A
Completed	`NCT01162200` - Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer	Phase 1
Completed	`NCT01965522` - Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer	Phase 2
Completed	`NCT00309569` - Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients	Phase 3
Terminated	`NCT01545648` - Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer	Phase 2
Completed	`NCT02428114` - A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)	N/A
Active, not recruiting	`NCT02685332` - Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA	Phase 1
Completed	`NCT02159157` - A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer	N/A
Completed	`NCT01871116` - POWER-remote Weight Loss Program in Early Stage Breast Cancer	N/A
Terminated	`NCT01166581` - Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates	N/A
Recruiting	`NCT06311357` - Percent Weight Change in the Medical Supplement Group of Early Breast Cancer	N/A
Terminated	`NCT02364960` - Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
Active, not recruiting	`NCT03561454` - A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients
Completed	`NCT02485678` - A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer	N/A
Active, not recruiting	`NCT02297672` - Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant	N/A
Completed	`NCT02335671` - Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy	N/A
Completed	`NCT03102307` - Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)